Leukine (sargramostim) / Partner Therap 
Welcome,         Profile    Billing    Logout  
 449 Diseases   58 Trials   58 Trials   3605 News 


«12...13141516171819202122232425»
  • ||||||||||  Leukine (sargramostim) / Partner Therap, Panvac-VF (falimarev/inalimarev) / Bavarian Nordic
    Combination therapy, Metastases:  Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer (clinicaltrials.gov) -  Jun 24, 2013   
    P2,  N=48, Active, not recruiting, 
    Active, not recruiting --> Completed N=25 --> 48
  • ||||||||||  Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
    Trial termination:  MT2004-30: Tomotherapy for Solid Tumors (clinicaltrials.gov) -  Jun 10, 2013   
    P1,  N=23, Terminated, 
    N=99 --> 147 Active, not recruiting --> Terminated; Replaced by another study
  • ||||||||||  Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
    Enrollment change:  MT2004-30: Tomotherapy for Solid Tumors (clinicaltrials.gov) -  Jun 10, 2013   
    P1,  N=23, Terminated, 
    Active, not recruiting --> Terminated; Replaced by another study N=45 --> 23
  • ||||||||||  Leukine (sargramostim) / Partner Therap
    Enrollment open:  Sargramostim for Myeloid Dendritic Cell Deficiency (clinicaltrials.gov) -  Jun 4, 2013   
    P1,  N=15, Recruiting, 
    Suspended --> Active, not recruiting Not yet recruiting --> Recruiting
  • ||||||||||  humanised dinutuximab (Hu14.18K322A) / Essential Pharma
    Enrollment change, Metastases:  Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) -  Jun 3, 2013   
    P2,  N=42, Recruiting, 
    Not yet recruiting --> Recruiting N=110 --> 42
  • ||||||||||  humanised dinutuximab (Hu14.18K322A) / Essential Pharma
    Enrollment open, Metastases:  Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) -  Jun 3, 2013   
    P2,  N=42, Recruiting, 
    N=110 --> 42 Not yet recruiting --> Recruiting
  • ||||||||||  humanised dinutuximab (Hu14.18K322A) / Essential Pharma
    New P2 trial, Metastases:  Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) -  May 16, 2013   
    P2,  N=42, Recruiting, 
  • ||||||||||  Leukine (sargramostim) / Partner Therap, NeuVax (nelipepimut-S) / Dr. Reddy's, Herceptin (trastuzumab) / Roche
    Enrollment open:  Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax (clinicaltrials.gov) -  Feb 13, 2013   
    P2,  N=300, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  Trial termination:  p53 Vaccine for Ovarian Cancer (clinicaltrials.gov) -  Jan 29, 2013   
    P2,  N=21, Terminated, 
    Active, not recruiting --> Terminated; Departure of PI Completed --> Terminated